S Kant Healthcare

S Kant Healthcare is a leading Indian pharmaceutical company specializing in the development, manufacturing, and global distribution of finished dosage forms and active pharmaceutical ingredients. As a member of the Sevantilal Kantilal (SK) Group, the company has established a significant international presence, particularly in the anti-malarial segment where it is a major supplier of artemisinin-based combination therapies. Their manufacturing operations are centered in a WHO-GMP certified facility in Vapi, India, which produces a wide range of therapeutic categories including antibiotics, cardiovascular agents, and anti-diabetics. Beyond its own branded generics, S Kant Healthcare serves as a strategic contract development and manufacturing organization (CDMO) for numerous multinational pharmaceutical partners. The company exports its products to over 40 countries across Africa, Southeast Asia, and Latin America.